Bunker Industria Farmaceutica Ltda. Report issue

For profit Phase 3
Founded: Sao Paulo Brazil (1975)
Status: Defunct (2019)

Organization Overview

First Clinical Trial
2009
NCT00944502
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2009

Timeline

NOW
  • Now

Active Ingredients

Drugs in Phase 3 Trials (1)

urea (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Neuralgia (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 1
  • # of Trial APIs: 1